{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:18:41Z","timestamp":1791173921635,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,12,14]],"date-time":"2013-12-14T00:00:00Z","timestamp":1386979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00277-013-1987-7","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T04:02:29Z","timestamp":1386907349000},"page":"1439-1440","source":"Crossref","is-referenced-by-count":20,"title":["Successful vemurafenib salvage treatment in a patient with primary refractory hairy cell leukemia and pulmonary aspergillosis"],"prefix":"10.1007","volume":"93","author":[{"given":"Helga","family":"Maurer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Wengenmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"L\u00fcbbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justus","family":"Duyster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zeiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,14]]},"reference":[{"key":"1987_CR1","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","volume":"364","author":"E Tiacci","year":"2011","unstructured":"Tiacci E, Trifonov V, Schiavon G et al (2011) Braf mutations in hairy-cell leukemia. N Engl J Med 364:2305\u20132315","journal-title":"N Engl J Med"},{"key":"1987_CR2","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMc1202124","volume":"366","author":"S Dietrich","year":"2012","unstructured":"Dietrich S, Glimm H, Andrulis M et al (2012) Braf inhibition in refractory hairy-cell leukemia. N Engl J Med 366:2038\u20132040","journal-title":"N Engl J Med"},{"key":"1987_CR3","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.3324\/haematol.2012.082404","volume":"98","author":"F Peyrade","year":"2013","unstructured":"Peyrade F, Re D, Ginet C et al (2013) Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a v600e mutation. Haematologica 98:e20\u2013e22","journal-title":"Haematologica"},{"key":"1987_CR4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.12201","volume":"161","author":"G Follows","year":"2013","unstructured":"Follows G, Sims H, Bloxham D et al (2013) Rapid response of biallelic braf v600e mutated hairy cell leukaemia to low dose vemurafenib. Br J Haematol 161:150\u2013153","journal-title":"Br J Haematol"},{"key":"1987_CR5","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1200\/JCO.2012.45.7739","volume":"31","author":"J Munoz","year":"2013","unstructured":"Munoz J, Schlette E, Kurzrock R (2013) Rapid response to vemurafenib in a heavily pretreated patient with hairy cell leukemia and a braf mutation. J Clin Oncol 31:e351\u2013e352","journal-title":"J Clin Oncol"},{"key":"1987_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/CCO.0b013e3283436e8c","volume":"23","author":"C Robert","year":"2011","unstructured":"Robert C, Arnault JP, Mateus C (2011) Raf inhibition and induction of cutaneous squamous cell carcinoma. Curr Opin Oncol 23:177\u2013182","journal-title":"Curr Opin Oncol"},{"key":"1987_CR7","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1200\/JCO.2011.41.1660","volume":"30","author":"L Zimmer","year":"2012","unstructured":"Zimmer L, Hillen U, Livingstone E et al (2012) Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective braf inhibition. J Clin Oncol 30:2375\u20132383","journal-title":"J Clin Oncol"},{"key":"1987_CR8","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1200\/JCO.2012.45.9495","volume":"31","author":"S Dietrich","year":"2013","unstructured":"Dietrich S, H\u00fcllein S, Hundemer M et al (2013) Continued response off treatment after braf inhibition in refractory hairy cell leukemia. J Clin Oncol 31:e300\u2013e303","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1987-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1987-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1987-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:49:48Z","timestamp":1559022588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1987-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,14]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["1987"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1987-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733061218.793544956","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,14]]}}}